The SAP family of adaptors in immune regulation.

[1]  B. Schraven,et al.  Adaptors and linkers in T and B cells. , 2004, Current opinion in immunology.

[2]  E. Romeo,et al.  Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells , 2004, European journal of immunology.

[3]  S. Latour,et al.  Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors , 2004, Molecular and Cellular Biology.

[4]  A. Thrasher,et al.  SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. , 2004, Blood.

[5]  S. Feske,et al.  The Cell Surface Receptor SLAM Controls T Cell and Macrophage Functions , 2004, The Journal of experimental medicine.

[6]  A. Veillette SLAM Family Receptors Regulate Immunity with and without SAP-related Adaptors , 2004, The Journal of experimental medicine.

[7]  Megan E. McNerney,et al.  2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells , 2004, The Journal of experimental medicine.

[8]  M. Eck,et al.  SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9. , 2004, International immunology.

[9]  M. van Lookeren Campagne,et al.  NTB-A, a New Activating Receptor in T Cells That Regulates Autoimmune Disease* , 2004, Journal of Biological Chemistry.

[10]  Zhao-Qi Wang,et al.  Mice deficient in the X‐linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus‐68 and hypo‐gammaglobulinemia , 2003, Journal of medical virology.

[11]  M. Eck,et al.  The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease , 2003, Nature Reviews Immunology.

[12]  S. Tangye,et al.  Functional Requirements for Interactions Between CD84 and Src Homology 2 Domain-Containing Proteins and Their Contribution to Human T Cell Activation 1 , 2003, The Journal of Immunology.

[13]  W. Knapp,et al.  SLAM-associated Protein Deficiency Causes Imbalanced Early Signal Transduction and Blocks Downstream Activation in T Cells from X-linked Lymphoproliferative Disease Patients* , 2003, Journal of Biological Chemistry.

[14]  A. Fischer,et al.  Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis , 2003, Current opinion in rheumatology.

[15]  S. Latour,et al.  The SLAM family of immune-cell receptors. , 2003, Current opinion in immunology.

[16]  M. Nishimura,et al.  Cutting Edge: The NK Cell Receptor 2B4 Augments Antigen-Specific T Cell Cytotoxicity Through CD48 Ligation on Neighboring T Cells1 , 2003, The Journal of Immunology.

[17]  C. Denny,et al.  Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. , 2003 .

[18]  S. Latour,et al.  Molecular and immunological basis of X‐linked lymphoproliferative disease , 2003, Immunological reviews.

[19]  P. Schwartzberg,et al.  Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation , 2003, Nature Cell Biology.

[20]  M. Eck,et al.  SAP couples Fyn to SLAM immune receptors , 2003, Nature Cell Biology.

[21]  R. Ahmed,et al.  SAP is required for generating long-term humoral immunity , 2003, Nature.

[22]  A. Thrasher,et al.  X‐linked lymphoproliferative disease: clinical, diagnostic and molecular perspective , 2002, British journal of haematology.

[23]  J. Rowley,et al.  Silencing of B Cell Receptor Signals in Human Naive B Cells , 2002, The Journal of experimental medicine.

[24]  V. Kuchroo,et al.  The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon γ production , 2002 .

[25]  S. S. Chuang,et al.  CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. , 2002, Molecular immunology.

[26]  J. Schatzle,et al.  2B4 Is Constitutively Associated with Linker for the Activation of T Cells in Glycolipid-Enriched Microdomains: Properties Required for 2B4 Lytic Function1 , 2002, The Journal of Immunology.

[27]  S. Tangye,et al.  CD84 is up‐regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT‐2 , 2002, European journal of immunology.

[28]  R. Tan,et al.  Association of the X-linked Lymphoproliferative Disease Gene Product SAP/SH2D1A with 2B4, a Natural Killer Cell-activating Molecule, Is Dependent on Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.

[29]  R. Biassoni,et al.  Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Yusuke Yanagi,et al.  The Morbillivirus Receptor SLAM (CD150) , 2002, Microbiology and immunology.

[31]  A. Veillette The SAP Family: A New Class of Adaptor-Like Molecules That Regulates Immune Cell Functions , 2002, Science's STKE.

[32]  Tony Pawson,et al.  A ‘three‐pronged’ binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome , 2002, The EMBO journal.

[33]  H. Ljunggren,et al.  Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions1 , 2001, The Journal of Immunology.

[34]  D. Speiser,et al.  The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector αβ T Cells1 , 2001, The Journal of Immunology.

[35]  S. S. Chuang,et al.  2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-γ Release in Human NK Cells Involves Distinct Pathways1 , 2001, The Journal of Immunology.

[36]  M. Colonna,et al.  Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family1 , 2001, The Journal of Immunology.

[37]  Pablo Engel,et al.  CD84 Functions as a Homophilic Adhesion Molecule and Enhances IFN-γ Secretion: Adhesion Is Mediated by Ig-Like Domain 11 , 2001, The Journal of Immunology.

[38]  Jack R. Davis,et al.  Characterization of SH2D1A Missense Mutations Identified in X-linked Lymphoproliferative Disease Patients* , 2001, The Journal of Biological Chemistry.

[39]  G. Cheng,et al.  Signaling Lymphocytic Activation Molecule Is Expressed on CD40 Ligand-Activated Dendritic Cells and Directly Augments Production of Inflammatory Cytokines1 , 2001, The Journal of Immunology.

[40]  T. Derfuss,et al.  Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity , 2001, European journal of immunology.

[41]  J. Jung,et al.  Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome1 , 2001, The Journal of Immunology.

[42]  E. Meinl,et al.  Signaling Lymphocytic Activation Molecule Is Expressed on Mature CD83+ Dendritic Cells and Is Up-Regulated by IL-1β1 , 2001, The Journal of Immunology.

[43]  L. Notarangelo,et al.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.

[44]  T. Pawson,et al.  Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product , 2001, Nature Immunology.

[45]  L. Vanes,et al.  Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. , 2001 .

[46]  P. Engel,et al.  Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. , 2001, Blood.

[47]  A. Sher,et al.  Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  N. Villamor,et al.  Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. , 2001, Blood.

[49]  P. Borrow,et al.  SAP controls T cell responses to virus and terminal differentiation of TH2 cells , 2001, Nature Immunology.

[50]  C. Richardson,et al.  CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. , 2001, Virology.

[51]  R. Biassoni,et al.  Analysis of the molecular mechanism involved in 2B4‐mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells , 2000, European journal of immunology.

[52]  M. Colonna,et al.  Patients with X‐linked lymphoproliferative disease have a defect in 2B4 receptor‐mediated NK cell cytotoxicity , 2000, European journal of immunology.

[53]  H. Ruley,et al.  Ly108: a new member of the mouse CD2 family of cell surface proteins , 2000, Immunogenetics.

[54]  Eric O Long,et al.  Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244)1 , 2000, The Journal of Immunology.

[55]  S. Tangye,et al.  Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome1 , 2000, The Journal of Immunology.

[56]  D I Stuart,et al.  Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. , 2000, The Journal of biological chemistry.

[57]  L. Notarangelo,et al.  X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .

[58]  P. Pizcueta,et al.  Gene structure of the mouse leukocyte cell surface molecule Ly9 , 2000, Immunogenetics.

[59]  S. Tangye,et al.  The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. , 2000, Seminars in immunology.

[60]  R. Biassoni,et al.  2B4 functions as a co‐receptor in human NK cell activation , 2000, European journal of immunology.

[61]  T. Pawson,et al.  Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A , 1999, Current Biology.

[62]  S. Tangye,et al.  Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. , 1999, Journal of immunology.

[63]  C Terhorst,et al.  Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. , 1999, Molecular cell.

[64]  S. Tangye,et al.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.

[65]  M. Colonna,et al.  Activating interactions in human NK cell recognition: the role of 2B4‐CD48 , 1999, European journal of immunology.

[66]  A. Neil Barclay,et al.  2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 , 1998, The Journal of experimental medicine.

[67]  E. Snyder,et al.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[69]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[70]  P. Pizcueta,et al.  CD84 leukocyte antigen is a new member of the Ig superfamily. , 1997, Blood.

[71]  B. Cocks,et al.  Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes , 1997, The Journal of experimental medicine.

[72]  C. Denny,et al.  EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. , 1996, Oncogene.

[73]  Jack R. Davis,et al.  X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery , 1995, Pediatric Research.

[74]  K. Ariizumi,et al.  2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors. , 1995, The Journal of investigative dermatology.

[75]  B. Cocks,et al.  A novel receptor involved in T-cell activation , 1995, Nature.

[76]  M. Bennett,et al.  Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[77]  G. Trinchieri,et al.  Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes , 1993, The Journal of experimental medicine.

[78]  A. Purohit,et al.  A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[79]  S. Argov,et al.  Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome. , 1986, Cellular immunology.

[80]  D. Purtilo,et al.  Cell‐mediated immunity to Epstein‐Barr virus (EBV) and natural killer (NK)‐cell activity in the X‐linked lymphoproliferative syndrome , 1982, International journal of cancer.

[81]  D. Purtilo,et al.  Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. , 1980, Science.

[82]  G. Vawter,et al.  X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.

[83]  B. Bower,et al.  WATER INTOXICATION AND MIST-TENT THERAPY , 1974 .

[84]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[85]  P. Engel,et al.  X-linked lymphoproliferative disease: a progressive immunodeficiency. , 2001, Annual review of immunology.